US poised to negotiate drug prices despite fierce pharma lobbying
Por um escritor misterioso
Descrição
Makers of blockbuster drugs including Eli Lilly, AbbVie and AstraZeneca face new curbs
US poised to negotiate drug prices despite fierce pharma lobbying
What you should know about drug price reform : Shots - Health News
Medicare's new powers to control drug prices to face lobbying and
Will Allowing Medicare to Negotiate Prices of Prescription Drugs
An Analysis of the Blizzard of Lawsuits to Block Drug-Price
Democrats plan crackdown on rising drug costs
PUMPING IRONY: A Tough Pill to Swallow
Federal judge won't block Medicare from negotiating drug prices
Hedgepaper 76: Pharma's Failed Promise: How Big Pharma Hurts
AARP, Big Pharma locked in battle over drug pricing bill
Medicare price negotiation: Putnam's round one picks - Putnam
US pharma industry 'seething' over drug pricing policy
How PhRMA is trying to thwart Democrats' effort to lower drug prices
The slippery slope is powerful': Dems believe drug pricing law
How Will Big Pharma Fare Under Trump? - Knowledge at Wharton
de
por adulto (o preço varia de acordo com o tamanho do grupo)
